Search

Your search keyword '"Verkade, Henkjan"' showing total 1,269 results

Search Constraints

Start Over You searched for: Author "Verkade, Henkjan" Remove constraint Author: "Verkade, Henkjan"
1,269 results on '"Verkade, Henkjan"'

Search Results

3. Longitudinal relationship between albuminuria in infancy and childhood

4. Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

7. Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia.

9. Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

11. Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency

13. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial

17. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

25. Genotype correlates with the natural history of severe bile salt export pump deficiency

33. Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials

36. Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70−/− Mice with a Human-like Bile Acid Composition

38. P1 Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database

39. Bile Acid Sequestration by Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70-/- Mice with a Human-Like Bile Acid Composition

41. Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency

46. Odevixibat therapy following liver transplantation in patients with FIC1-deficient progressive familial intrahepatic cholestasis: a retrospective case series

47. Efficacy and safety outcomes with odevixibat treatment: Pooled data from the phase 3 ASSERT and ASSERT-EXT studies in patients with Alagille syndrome

48. Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database

49. Serum bile acids are associated with native liver survival in patients with Alagille syndrome: results from the GALA study group

Catalog

Books, media, physical & digital resources